NeoGenomics Announces Preliminary Fourth Quarter and Full-Year 2025 Revenue
NeoGenomics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
NeoGenomics Appoints Diagnostics and Lab Services Industry Veteran John P. “Jack” Kenny to its Board of Directors
